Therapy areas

Abcam to Report Interim Results on Monday, March 8, 2021

Abcam to Report Interim Results on Monday, March 8, 2021

Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal...

Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO

Amneal Reports Fourth Quarter and Full Year 2020 Financial Results

Amneal Reports Fourth Quarter and Full Year 2020 Financial Results

Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO

Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO

Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application...

Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)